Feedback / Questions
Cavaltinib (curcumin based cavaltinib) - Naturally Splendid
https://www.proactiveinvestors.com/companies/news/945649/naturally-splendid-enterprises-moving-to-selecting-subjects-for-phase-2-clinical-trial-to-evaluate-cavaltinib-as-coronavirus-treatment-945649.html
Apr 1, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next